Skip to main content
. 2015 Feb 9;2(1):e000018. doi: 10.1136/bmjgast-2014-000018

Figure 3.

Figure 3

Changes in secondary outcome measures from baseline to 18 weeks (Gp, group; VAS, visual analogue scale).The beneficial effect of VSL#3 seems to be maintained throughout the 18 weeks study period, observed as continued significant improvement in stool frequency, stool mucus and well-being.